NCT02511067View on ClinicalTrials.gov

Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 1, 2016

Primary Completion Date

October 5, 2016

Study Completion Date

October 5, 2016

Conditions

Diabetic Macular Edema

Interventions

DRUG

Tocilizumab

Intravenous Infusion of Tocilizumab ( 8.0 mg/kg)

DRUG

Ranibizumab

Intravitreal injection of Ranibizumab (0.3mg)

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of Nebraska

OTHER